Evidence map›Paper›PMID 39685206›Full record

ReviewMaterials (Basel, Switzerland)2024

A Review of Chitosan-Based Materials for Biomedical, Food, and Water Treatment Applications.

Dan Chicea, Alexandra Nicolae-Maranciuc

Abstract readReview
In one paragraph

Review in Materials (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Sustainable Synthesis of FeNanomaterials (Basel, Switzerland) · 2026
    Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. A Review on Biodegradable Materials of Sustainable Soft Robotics and Electronics.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  7. Article
  8. Review
  9. Review
  10. Prolonged Antimicrobial Effects ofInternational journal of microbiology · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Dan ChiceaResearch Center for Complex Physical Systems, Faculty of Sciences, Lucian Blaga University of Sibiu, 550012 Sibiu, Romania.ORCID 0000-0001-8074-9107
Alexandra Nicolae-MaranciucResearch Center for Complex Physical Systems, Faculty of Sciences, Lucian Blaga University of Sibiu, 550012 Sibiu, Romania.ORCID 0000-0003-0742-241X

Funding

Lucian Blaga University of Sibiu LBUS-IRG-2023
6 · The paper itself

Abstract

Chitosan, a natural biopolymer with excellent biocompatibility, biodegradability, and modifiable structure, has broad applications in regenerative medicine, tissue engineering, food packaging, and environmental technology. Its abundance, solubility in acidic solutions, and capacity for chemical modification make it highly adaptable for creating specialized derivatives with enhanced properties. Recent advances have demonstrated chitosan's efficacy in composite systems for tissue regeneration, drug delivery, and antimicrobial applications. This review examines chitosan's unique properties, with a focus on its antibacterial activity as influenced by factors like pH, concentration, molecular weight, and deacetylation degree. Additionally, chitosan's potential as a sustainable, non-toxic material for eco-friendly packaging and water treatment is explored, highlighting the growing interest in chitosan composites with other polymers and metallic nanoparticles for enhanced biomedical and environmental applications.

Indexed as

antibacterial activitybiodegradablebiomaterialbioprintingchitosandrug delivery systemsfood packaginghydrogeltissue engineeringwater treatment

Identifiers

PMID39685206
PMCPMC11642024

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.